Literature DB >> 21041788

Common pathogenic pathways in melanoma and Parkinson disease.

Coro Paisán-Ruiz1, Henry Houlden.   

Abstract

There is growing evidence in the scientific literature for shared risk and overlapping disease mechanisms in the development of cancer and Parkinson disease (PD). This association has recently been highlighted with respect to melanoma and PD. Therefore, we review and discuss the literature concerning this unexplained link. A striking overlap is observed in the tyrosine and L-dopa biosynthetic pathways suggesting a common disease mechanism associated with these 2 heterogeneous disorders that warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21041788     DOI: 10.1212/WNL.0b013e3181fb4466

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  16 in total

1.  Malignant melanoma, breast cancer and other cancers in patients with Parkinson's disease.

Authors:  Kathrine Rugbjerg; Søren Friis; Christina Funch Lassen; Beate Ritz; Jørgen H Olsen
Journal:  Int J Cancer       Date:  2012-03-22       Impact factor: 7.396

Review 2.  Meta-analysis of the relationship between Parkinson disease and melanoma.

Authors:  Rui Liu; Xiang Gao; Yi Lu; Honglei Chen
Journal:  Neurology       Date:  2011-06-07       Impact factor: 9.910

3.  Treatment with diphenyl-pyrazole compound anle138b/c reveals that α-synuclein protects melanoma cells from autophagic cell death.

Authors:  Elisa Turriani; Diana F Lázaro; Sergey Ryazanov; Andrei Leonov; Armin Giese; Margarete Schön; Michael P Schön; Christian Griesinger; Tiago F Outeiro; Donna J Arndt-Jovin; Dorothea Becker
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-05       Impact factor: 11.205

4.  Smoking and risk of skin cancer: a prospective analysis and a meta-analysis.

Authors:  Fengju Song; Abrar A Qureshi; Xiang Gao; Tricia Li; Jiali Han
Journal:  Int J Epidemiol       Date:  2012-10-11       Impact factor: 7.196

5.  The role of the melanoma gene MC1R in Parkinson disease and REM sleep behavior disorder.

Authors:  Ziv Gan-Or; Noreen Mohsin; Simon L Girard; Jacques Y Montplaisir; Amirthagowri Ambalavanan; Stephanie Strong; Victoria Mallett; Sandra B Laurent; Cynthia V Bourassa; Michel Boivin; Melanie Langlois; Isabelle Arnulf; Birgit Högl; Birgit Frauscher; Christelle Monaca; Alex Desautels; Jean-François Gagnon; Ronald B Postuma; Patrick A Dion; Yves Dauvilliers; Nicolas Dupre; Roy N Alcalay; Guy A Rouleau
Journal:  Neurobiol Aging       Date:  2016-04-06       Impact factor: 4.673

6.  Potential impact of self-perceived prodromal symptoms on the early diagnosis of Parkinson's disease.

Authors:  Uwe Walter; Sabine Kleinschmidt; Florian Rimmele; Christian Wunderlich; Irene Gemende; Reiner Benecke; Knut Busse
Journal:  J Neurol       Date:  2013-10-02       Impact factor: 4.849

7.  The role of alpha-synuclein in melanin synthesis in melanoma and dopaminergic neuronal cells.

Authors:  Tianhong Pan; Julie Zhu; Wen-Jen Hwu; Joseph Jankovic
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

8.  Analysis of alpha-synuclein in malignant melanoma - development of a SRM quantification assay.

Authors:  Charlotte Welinder; Göran B Jönsson; Christian Ingvar; Lotta Lundgren; Bo Baldetorp; Håkan Olsson; Thomas Breslin; Melinda Rezeli; Bo Jansson; Thomas E Fehniger; Thomas Laurell; Elisabet Wieslander; Krzysztof Pawlowski; György Marko-Varga
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

Review 9.  Chronic Inflammation Links Cancer and Parkinson's Disease.

Authors:  Zhiming Li; Zaozao Zheng; Jun Ruan; Zhi Li; Chi-Meng Tzeng
Journal:  Front Aging Neurosci       Date:  2016-06-03       Impact factor: 5.750

Review 10.  The associations between Parkinson's disease and cancer: the plot thickens.

Authors:  Danielle D Feng; Waijiao Cai; Xiqun Chen
Journal:  Transl Neurodegener       Date:  2015-10-26       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.